Specifications include, but are not limited to: All technical requirements must be met: Data sets should include Drug Enforcement Agency (DEA) Controlled substances for all Schedule 2 to 5 drugs. (Weight: 15%) NDC data should be available for both formatted (10-digit) and unformatted (11-digit, dashes removed) NDC numbers, to ensure the records import and can be found correctly. (Weight: 15%) Drug trade and generic names, delivery method, and dosage should be provided in two formats, 1-individually and 2- combined as a single value for easy display and analysis. (Weight: 13%) Morphine Milligram Equivalent (MME) factors and drug strength should be included as numeric values to enable use in MME calculations. (Weight: 13%) NDC data should include the ability to identify drug categories, for example: Narcotic/Opioid, Stimulant, Muscle Relaxant, Benzodiazepines, Depressants, Hallucinogens, etc. (Weight: 8%) NDC data should include all known adverse drug interactions for controlled substances, schedule II-V, and applicable warning text to allow the CSD the ability to alert practitioners, if necessary. (Weight: 8%) Data dictionary and technical documentation should be comprehensive, easy-to-understand, and user-friendly. (Weight: 8%) Full data set should be available to push or pull on a scheduled, automated basis (Weight: 5%) Data set should be regularly updated to ensure timeliness of new, revised, and discontinued drug data. (Please include the periodicity of your updates.) (Weight: 5%)